Circulating RNAs in Acute Congestive Heart Failure

Active, not recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

August 17, 2016

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Acute Congestive Heart FailureHeart Failure With Reduced Ejection FractionHeart Failure With Normal Ejection Fraction
Interventions
DIAGNOSTIC_TEST

Cardiac MRI

Cardiac MRI is a test that allows us to look at how the heart muscle works and the amount of scar tissue in your heart. Screening questions will be asked to make sure that patients are not pregnant, and that they have kidney function tests to confirm that IV contrast used (gadolinium) during the MRI is safe for them.

Trial Locations (3)

02114

Massachusetts General Hospital, Boston

02115

Brigham and Women's Hospital, Boston

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
collaborator

Beth Israel Deaconess Medical Center

OTHER

collaborator

Brigham and Women's Hospital

OTHER

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

American Heart Association

OTHER

lead

Massachusetts General Hospital

OTHER

NCT03345446 - Circulating RNAs in Acute Congestive Heart Failure | Biotech Hunter | Biotech Hunter